Contract 75H71020F80193
Roche Diabetes Care Inc · Department Of Health And Human Services · December 13, 2019
Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on December 13, 2019 for $668,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Gallup, NM. This is a task or delivery order issued under parent IDIQ V797D50597. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 20, 2023.
Contract details
- PIID
- 75H71020F80193
- Parent IDIQ
- V797D50597
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Gallup, NM
- First action
- December 13, 2019
- Latest action
- October 20, 2023
Description
DE-OBLIGATE AND CLOSE OUT
Modification timeline
-
October 20, 2023Mod P00005$-293
-
September 11, 2020Mod P00004ADD FUNDS - MOD 4$68.0K
-
July 9, 2020Mod P00003ADD FUNDS - MOD 3$50.0K
-
March 30, 2020Mod P00002ADD FUNDS TO BULK FUNDED PO - MOD 2$150.0K
-
February 19, 2020Mod P00001ADD FUNDS TO BULK FUNDED PO - MOD 1$150.0K
-
December 13, 2019Base awardDIABETIC TESTING DEVICE KITS, LANCETS AND TEST STRIPS$250.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71020F80193?
Contract 75H71020F80193 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on December 13, 2019 for $668,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 75H71020F80193?
Roche Diabetes Care Inc won contract 75H71020F80193 from Department Of Health And Human Services.
How much is contract 75H71020F80193 worth?
Contract 75H71020F80193 has obligated $668,000 to date.